Divi's Laboratories Ltd (NSE:DIVISLAB)
₹ 3896.2 118 (3.11%) Market Cap: 1.03 Til Enterprise Value: 998.21 Bil PE Ratio: 72.80 PB Ratio: 7.94 GF Score: 97/100

Q3 2022 Divi's Laboratories Ltd Earnings Call Transcript

Feb 11, 2022 / 08:30AM GMT
Release Date Price: ₹4291.25 (-0.52%)
Operator

Ladies and gentlemen, good day, and welcome to the earnings conference call of Divi's Laboratories Limited for the Q3 of financial year 2022. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. M. Satish Choudhury. Thank you, and over to you, sir.

M. Satish Choudhury;s Laboratories Limited;Company Secretary;Compliance Officer
Divi

'-&

Good afternoon to all of you. I'm M. Satish Choudhury, Company Secretary and Chief Investor Relations Officer of Divi's Laboratories Limited. I welcome you all to the earnings call for the quarter ended December 31, 2021.

From Divi's Labs, we have with us today Dr. Murali K. Divi, Managing Director; Ms. Nilima Prasad Divi, Whole-Time Director, Commercial; Mr. L. Kishore Babu, Chief Financial Officer; and Mr. Venkatesa Perumallu, General Manager, Finance and Accounts.

During the day, our Board has approved the results for the quarter and 9 months ended December 31, 2021, and we have released

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot